The Rising Demand for Minimally Invasive Surgeries drives the demand for the U.S., China, and Europe Laparoscopic Surgical Robotic Devices Market

Minimally invasive surgery involves the surgical procedure performed with minute incisions on the body. Various minimally invasive surgeries include repair of heart valves, mitral valve prolapse, angioplasty and other blockage removals in the body. The supremacy of MIS includes short recovery time, low risk of infection, less bleeding, small scars, and shorter hospital stays.

Access Full Report @ https://www.databridgemarketresearch.com/reports/us-china-and-europe-laparoscopic-surgical-robotic-devices-market

Various surgeries are performed using minimally invasive surgical options with small incisions, unlike the traditional techniques in which large incisions are made.

For instance,

• In May 2022, Medacta International launched the innovative AMIS (Anterior Minimally Invasive Surgery) technique. The minimally invasive surgery helped in hip replacement procedure and resulted in increase in product portfolio and a rise in sales.

Data Bridge Market Research analyzes that the U.S. China, and Europe Laparoscopic Surgical Robotic Devices Market is expected to grow with a CAGR of 12.7% in the forecast period of 2023 to 2030 and is expected to reach USD 10,566.76 million by 2030 in the U.S. The instruments and accessories segment is projected to propel the market growth as the development of teleoperated surgical robotic systems. 

Key Findings of the Study

Strategic Initiatives by Key Market Players

Strategic initiatives such as acquisition, partnership, contract agreement, and participation in conferences provide an opportunity to flourish their customer base geographically. Both market players open the door to additional or new resources such as technology and talent.

For instance,

• In February 2021, Medtronic acquired Digital Surgery, a privately held company specializing in digital education, data analytics and training. With the acquisition, Medtronic aims to strengthen its robot-assisted surgery platform and expand its range of robotic systems by adding a new robot called Hugo

Therefore, it is predicted that strategic initiative is the golden opportunity for the market players to accelerate their revenue growth in the US, China and Europe laparoscopic surgical robotic devices market.

Report Scope and Market Segmentation

Segment Analysis:

The US, China, and Europe laparoscopic surgical robotic devices market is categorized into five segments: product type, application, end user, and distribution channel.

• On the basis of product type US, China, and Europe laparoscopic surgical robotic devices market is segmented into robotic system/machine, instruments and accessories. In 2023, the instruments and accessories segment is expected to dominate the U.S. laparoscopic surgical robotic devices market with 56.15% market share.  In 2023, the instruments and accessories segment is expected to dominate the China laparoscopic surgical robotic devices market with 56.72% market share.  In 2023, the instruments and accessories segment is expected to dominate the Europe laparoscopic surgical robotic devices market with 55.15% market share.

In 2023, the instruments and accessories segment is expected to dominate the market due to the rising demand for robotic instruments and accessories for minimally invasive surgeries.

• On the basis of application US, China, and Europe laparoscopic surgical robotic devices market is segmented into urological surgeries, gynecological surgeries, general surgeries, colorectal surgeries, gastrointestinal surgeries and others. In 2023, the urological surgeries segment is expected to dominate the U.S. laparoscopic surgical robotic devices market with 26.00% market share.  In 2023, the urological surgeries segment is expected to dominate the China laparoscopic surgical robotic devices market with 26.80% market share.  In 2023, the urological surgeries segment is expected to dominate the Europe laparoscopic surgical robotic devices market with 26.00% market share.
• On the basis of end user the US, China, and Europe laparoscopic surgical robotic devices market is segmented into hospitals, ambulatory surgical centers and others. In 2023, the hospitals segment is expected to dominate the U.S. laparoscopic surgical robotic devices market with 63.58% market share.  In 2023, the hospitals segment is expected to dominate the China laparoscopic surgical robotic devices market with 63.90% market share.  In 2023, the hospitals segment is expected to dominate the Europe laparoscopic surgical robotic devices market with 63.58% market share.
• On the basis of distribution channel, the US, China, and Europe laparoscopic surgical robotic devices market is segmented into direct tender, retail sales and others. In 2023, the direct tender segment is expected to dominate the U.S. laparoscopic surgical robotic devices market with 67.24% market share.  In 2023, the direct tender segment is expected to dominate the China laparoscopic surgical robotic devices market with 67.89% market share.  In 2023, the direct tender segment is expected to dominate the Europe laparoscopic surgical robotic devices market with 67.24% market share.

Major Players

Data Bridge Market Research recognizes the following companies as the market players in the U.S., China, and Europe laparoscopic surgical robotic devices market that include Medtronic (U.S.), Intuitive Surgical (U.S.), Zimmer Biomet (U.S.), Stryker (U.S.), Smith+Nephew (U.K.), Siemens Healthcare GmbH (Germany), Johnson & Johnson (U.S.), Titan Medical Inc. (Canada), Asensus Surgical US, Inc. (U.S.), CONMED Corporation (U.S.), Olympus America (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Brainlab AG (Germany), Momentis Innovative Surgery, Virtual Incision (Germany), Richard Wolf GmbH (Germany), Microline Surgical (U.S.), ENDOQUEST ROBOTICS (U.S.), CUREXO, INC. (South Korea), among others.

Market Development

• In February 2022, Stryker will complete the acquisition of Vocera Communications. This acquisition provides significant opportunities to advance innovations and accelerate our digital aspirations.
• In February 2021, Medtronic acquired Digital Surgery, a privately held company specializing in digital education, data analytics and training. With the acquisition, Medtronic aims to strengthen its robot-assisted surgery platform and expand its range of robotic systems by adding a new robot called Hugo.
• In January 2021, Smith & Nephew announced that the company had acquired the Extremity Orthopaedics business of the Integra LifeSciences Holdings Corporation. This results in expanding the product portfolio of the company in the market.
• In December 2020, Zimmer Biomet announced that the company had acquired A&E Medical with a complete sternal closure devices portfolio. This acquisition results in increasing the portfolio leading to increased sales and demands for its product in the market which will further increase its revenue in future.
• In December 2019, Johnson & Johnson Services, Inc. underwent a strategic collaboration agreement with Verb Surgical Inc. to make medical interventions smarter, less invasive, and more personalized. This agreement results in increasing credibility in the market.

Regional Analysis

Geographically, the countries covered in the transfection reagents and equipment market report are U.S.,  China, Germany, France,  U.K.,  Italy, Spain, Russia, Netherlands, Switzerland, Turkey,  Belgium, Poland, Norway, Denmark, Finland, Sweden,  Rest of Europe.

As per Data Bridge Market Research analysis:

U.S. is the dominant country in the laparoscopic robotic surgical devices market during the forecast period 2023-2030

In 2023, U.S. dominated the transfection reagents and equipment market owing to the higher level of investments by U.S. manufacturers and increasing prevalence of chronic diseases in U.S.  U.S. will continue to dominate the laparoscopic robotic surgical devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing adoption of advanced technology and launch of new products in this country. Additionally, the increasing number of cases of chronic problems and the rising development of teleoperated surgical systems are expected to further enhance the market's growth rate in the country. 

China is estimated to be the fastest growing country in the laparoscopic robotic surgical devices market for the forecast period 2023-2030

China is expected to grow during the forecast period due to the presence of major market players and the rapid development of medical facilities in emerging economies in the country. In addition to this, the rising level of healthcare expenditure and increasing per-capita income are expected to propel the market's growth rate in the country.

For more detailed information about the laparoscopic robotic surgical devices market report, click here – https://www.databridgemarketresearch.com/reports/us-china-and-europe-laparoscopic-surgical-robotic-devices-market